Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-03 4:18 pm Unchanged |
2025-03-31 | 13G | Ensysce Biosciences, Inc. ENSC |
PERCEPTIVE ADVISORS LLC | 86,666 5.300% |
0 (Unchanged) |
Filing History |
| 2025-02-14 6:34 pm Sale |
2024-12-31 | 13G | Ensysce Biosciences, Inc. ENSC |
RA Capital Management, L.P. | 0 0.000% |
-98,400 (Position Closed) |
Filing History |
| 2025-02-14 5:22 pm Purchase |
2024-12-31 | 13G | Ensysce Biosciences, Inc. ENSC |
Anson Funds Management LP | 411,681 2.100% |
346,111 (+527.85%) |
Filing History |
| 2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Ensysce Biosciences, Inc. ENSC |
PERCEPTIVE ADVISORS LLC | 86,666 0.400% |
86,666 (New Position) |
Filing History |
| 2024-11-14 5:52 pm Purchase |
2024-09-30 | 13G | Ensysce Biosciences, Inc. ENSC |
Anson Funds Management LP | 65,570 7.100% |
65,570 (New Position) |
Filing History |
| 2024-11-06 4:15 pm Purchase |
2024-10-30 | 13G | Ensysce Biosciences, Inc. ENSC |
RA Capital Management, L.P. | 98,400 9.900% |
98,400 (New Position) |
Filing History |
| 2024-10-29 5:27 pm Purchase |
2024-10-22 | 13G | Ensysce Biosciences, Inc. ENSC |
PERCEPTIVE ADVISORS LLC | 86,667 8.700% |
86,667 (New Position) |
Filing History |
| 2024-02-14 4:31 pm Sale |
2023-12-31 | 13G | Ensysce Biosciences, Inc. ENSC |
Lincoln Park Capital Fund LLC | 8,267 3.792% |
-72 (-0.86%) |
Filing History |
| 2023-07-17 6:15 pm Purchase |
2022-12-09 | 13D | Ensysce Biosciences, Inc. ENSC |
GOWER BOB G | 10,772 5.700% |
10,772 (New Position) |
Filing History |
| 2023-02-14 5:21 pm Sale |
2022-12-31 | 13G | Ensysce Biosciences, Inc. ENSC |
HG Vora Capital Management, LLC | 1,321 2.100% |
-660 (-33.31%) |
Filing History |
| 2023-02-14 11:20 am Sale |
2022-12-31 | 13G | Ensysce Biosciences, Inc. ENSC |
CVI Investments, Inc. | 1,872 4.900% |
-906 (-32.63%) |
Filing History |
| 2023-02-06 6:34 pm Purchase |
2023-02-02 | 13G | Ensysce Biosciences, Inc. ENSC |
Lincoln Park Capital Fund LLC | 8,339 9.990% |
8,339 (New Position) |
Filing History |
| 2022-12-16 10:24 am Purchase |
2022-12-07 | 13G | Ensysce Biosciences, Inc. ENSC |
CVI Investments, Inc. | 2,778 7.800% |
2,778 (New Position) |
Filing History |
| 2022-07-07 09:08 am Unchanged |
2022-06-30 | 13D | Ensysce Biosciences, Inc. ENSC |
Silvers Daniel B. | 801 7.900% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:46 pm Sale |
2021-12-31 | 13G | Leisure Acquisition Corp. LACQ |
Glazer Capital, LLC | 0 0.000% |
-18,932 (Position Closed) |
Filing History |
| 2022-02-14 4:06 pm Purchase |
2021-12-31 | 13G | Ensysce Biosciences, Inc. ENSC |
HG Vora Capital Management, LLC | 1,981 24.600% |
1,981 (New Position) |
Filing History |
| 2021-10-12 4:15 pm Unchanged |
2021-10-07 | 13D | Ensysce Biosciences, Inc. ENSC |
Silvers Daniel B. | 801 11.080% |
0 (Unchanged) |
Filing History |
| 2021-07-12 4:40 pm Purchase |
2021-06-30 | 13D | Ensysce Biosciences, Inc. ENSC |
Wright Richard Chester | 385 5.400% |
385 (New Position) |
Filing History |
| 2021-07-12 4:39 pm Purchase |
2021-06-30 | 13D | Ensysce Biosciences, Inc. ENSC |
Chang William H | 721 10.700% |
721 (New Position) |
Filing History |
| 2021-07-12 4:37 pm Purchase |
2021-06-30 | 13D | Ensysce Biosciences, Inc. ENSC |
GOWER BOB G | 2,202 32.600% |
2,202 (New Position) |
Filing History |